Baxter primarily concentrates on products which treat hemophilia, kidney disease, immune disorder and several other chronic conditions.
Baxter firstly expands its international operations in Belgium in 1954, after which it continues to grow in various international locations like India, China and several other countries.
Baxter International Inc. was founded back in 1931 by Donald Baxter, a medical doctor by profession. Baxter is a public company traded as NYSE: BAX primarily dealing in medical equipment. Baxter employed 61,500 employees by far.
Key people in Baxter’s succession include the names of Jose E. Almeida (Chairman & CEO), Jay Saccaro, (CFO) with a net income of $2.01 billion as per financial year 2014.
The company report analyses the company on different fronts including financial, product portfolio and competitive position of the firm. The financial analysis covers the analysis of company’s financial position using different ratios. Moreover, the report covers analysis of the segmental revenue shares and the geographies in which the company operates. The recent development chapter in the report provides the recent activities of the company such as mergers, acquisitions, new product developments and joint ventures.
- Introduction to Baxter International Inc.
- Contact Details
- Key Features
- Geographic Presence
- Financial Analysis
- Segment Revenue Shares
- Key Financial Ratios:
- Swot Analysis
- Product portfolio:
- Baxter International Inc.: Recent Developments
- Mergers and Acquisitions, Joint Ventures and Partnerships
- New Product launch
- Other developments